Medicure Inc (MPH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MPH Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Medicure Inc adapts cash usage as operating conditions change.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
0 0 0 (Dec 31 2024)
Operating Activities
Income0.00
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Adjustments For Decrease IncreaseIn Other Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Adjustments For Decrease Increase In Inventories-
Adjustments For Decrease Increase In Other Operating Receivables-
Adjustments For Increase Decrease In Trade Account Payable And Accrued Liabilities-
Interest Paid Received Classified As Operating Activities-
Income Taxes Paid Refund Classified As Operating Activities-
Adjustments For Finance Income Cost-
Increase Decrease Through Foreign Exchange And Other Movements Financial Assets-
Purchase Of Interests In Investments Accounted For Using Equity Method-
Proceeds From Sales Or Maturity Of Funds-
Proceeds From Purchase Of Short Term Investments Classified As Investment Activity-
Repayment Of Holdback Payable-
Acquisitions Of Property Plant And Equipment-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities0.00
Accounts Receivable0.00
Adjustments For Decrease IncreaseIn Trade Account Receivable0.17
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.80
Discontinued operations0.00
Net Cash flow from Operating Activities-0.43
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-1.56
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.56
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net2.25
Proceeds From Exercise Of Subsidiary Options-
Proceeds From Exercise Of Warrants-
Proceeds From Borrowings-
Cash Repayments Of Advances And Loans From Related Parties-
Decrease Increase In Cash In Escrow-
Payment Of Due To Vendor-
Increase Decrease Through Foreign Exchange Financial Assets-
Increase Decrease In Cash And Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.32
Effect of exchange rate on cash flow-0.26
Discontinued operations0.00
Free Cash Flow-0.43
Total Cash Flow-2.57
4 historic quarters locked

Sign in to unlock the full Medicure Inc cash flow history.

About Medicure Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: April 23, 2026
  • Source: med_20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001654954-26-003871

Figures are derived from filed reports and may be restated. Historical data is subject to revision.